Allworth Financial’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.88K | Buy |
135
+130
| +2,600% | +$3.74K | ﹤0.01% | 3393 |
|
|
2025
Q1 | $167 | Sell |
5
-4
| -44% | -$134 | ﹤0.01% | 3896 |
|
|
2024
Q4 | $348 | Sell |
9
-15
| -63% | -$580 | ﹤0.01% | 3679 |
|
|
2024
Q3 | $1.23K | Sell |
24
-6
| -20% | -$307 | ﹤0.01% | 3148 |
|
|
2024
Q2 | $1.58K | Buy |
30
+10
| +50% | +$527 | ﹤0.01% | 3021 |
|
|
2024
Q1 | $937 | Hold |
20
| – | – | ﹤0.01% | 3102 |
|
|
2023
Q4 | $712 | Sell |
20
-28
| -58% | -$997 | ﹤0.01% | 3053 |
|
|
2023
Q3 | $1.43K | Buy |
+48
| New | +$1.43K | ﹤0.01% | 2696 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$1.61K | – | 3280 |
|
|
2023
Q1 | $1.61K | Buy |
+100
| New | +$1.61K | ﹤0.01% | 2502 |
|
|
2022
Q4 | – | Sell |
-10
| Closed | – | – | 3044 |
|
|
2022
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 2729 |
|